Sagimet Biosciences Inc. (SGMT) › Operating Cash FlowSagimet Biosciences Inc. (SGMT) — Operating Cash FlowAnnual figures by period end, from SEC filings.2022-12-31: -$24.49M2023-12-31: -$23.77M2024-12-31: -$42.44M2025-12-31: -$45.65M-$45.65M2022-12-31Operating Cash Flow (USD)2025-12-31Period endedOperating Cash FlowChange YoYSource filing2025-12-31-$45.65M—2026-03-11From 2025-01-012024-12-31-$42.44M—2026-03-11From 2024-01-012023-12-31-$23.77M—2025-03-12From 2023-01-012022-12-31-$24.49M—2024-03-25From 2022-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)